ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 93 filers reported holding ADURO BIOTECH INC in Q3 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $808,000 | +3572.7% | 349,677 | +1617.8% | 0.00% | – |
| Q3 2019 | $22,000 | -70.7% | 20,356 | -58.4% | 0.00% | – |
| Q2 2019 | $75,000 | -14.8% | 48,923 | +121.5% | 0.00% | – |
| Q1 2019 | $88,000 | +137.8% | 22,090 | +58.9% | 0.00% | – |
| Q4 2018 | $37,000 | -86.4% | 13,902 | -62.5% | 0.00% | – |
| Q3 2018 | $272,000 | +1.9% | 37,037 | -2.8% | 0.00% | – |
| Q2 2018 | $267,000 | -52.8% | 38,093 | -37.4% | 0.00% | -100.0% |
| Q1 2018 | $566,000 | +106.6% | 60,896 | +66.9% | 0.00% | – |
| Q4 2017 | $274,000 | -3.9% | 36,497 | +36.5% | 0.00% | – |
| Q3 2017 | $285,000 | -11.2% | 26,732 | -4.9% | 0.00% | – |
| Q2 2017 | $321,000 | +93.4% | 28,123 | +82.3% | 0.00% | – |
| Q1 2017 | $166,000 | +9.2% | 15,424 | +15.9% | 0.00% | – |
| Q4 2016 | $152,000 | -29.3% | 13,305 | -23.3% | 0.00% | – |
| Q3 2016 | $215,000 | +50.3% | 17,336 | +37.1% | 0.00% | – |
| Q2 2016 | $143,000 | – | 12,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |